IDRC and the Minister of International Development, the Honourable Harjit Sajjan, are pleased to announce that Dr. Dorothy Nyambi has been appointed as Chairperson of IDRC’s Board of Governors, Nurjehan Mawani has been appointed as governor and Gilles Rivard, Purnima Mane and Akwasi Aidoo have been reappointed as governors.
Zulfiqar A. Bhutta, a long-time IDRC grantee, has been awarded the John Dirks Canada Gairdner 2022 Global Health Award “for the development and evaluation of evidence-based interventions in child and maternal health for marginalized populations, focusing on outcomes for the ‘first thousand days’ of life.”
Seven implementation research projects were selected by IDRC to advance sexual, reproductive and maternal health innovations in Africa using gender-transformative approaches. Gender-transformative research (GTR) involves examining, analyzing, and generating evidence on what works in addressing the root causes of gender inequalities to create lasting social change in households, communities, and institutions.
For many people, the raison d’être of global health is the achievement of health equity for all people worldwide. Reaffirming this view is the United Nations’ Sustainable Development Goal 3, which seeks to “ensure healthy lives and promote well-being for all at all ages.” Yet, after decades of programming and billions of dollars invested in global health, alarming health inequities persist across and within countries. The current COVID-19 pandemic has further exacerbated these health inequities, underscoring the need for the field of global health to do more and to do better.
IDRC is pleased to announce the projects and research teams selected for the Gender in STEM Research Initiative (GIST), which aims to increase the contribution of science to gender equality to advance women in science, technology, engineering and mathematics (STEM) and to increase gender analysis in STEM research.
In March 2020, the World Health Organization declared a pandemic due to the emergence of SARS-CoV2, which causes COVID-19, a potentially lethal respiratory infection. To date, apart from the novel Molnupiravir and Ritonavir, there are no orally or nasally administered antiviral agents to prevent or treat SARS-CoV2 infections.
With funding from IDRC, a research team from the Prospective Urban Rural Epidemiology (PURE) study, a large international population research effort coordinated by McMaster University’s Population Health Research Institute (PHRI), is studying why some people get COVID-19 and others do not.
“Rethinking Partnership Paradigms in Global Health” is the theme of the Canadian Conference on Global Health 2021 (CCGH 2021) taking place from November 24 to 26. It will be a hybrid event with most attendees attending virtually and small in-person sessions at the Delta Hotel in Ottawa.